LRRFIP1 is abnormally expressed in a variety of cancers [4–7] and regulates a wide range of biological systems and processes, including immune response to microorganisms and autoimmunity, remodeling of cytoskeletal system, signal transduction pathways, and transcriptional regulations of genes [8–11]. This evidence concerns the gene LRRFIP1 and cancer.